Also, the treatment with CSF1R inhibitors in mice leads to a reduced microglia-mediated accumulation of amyloid plaques56 and prevents the development of Alzheimer’s disease-like symptoms due to the anti-inflammatory effect of halting microglia proliferation57. This evidence concerns the gene CSF1R and early-onset autosomal dominant Alzheimer disease.